TY - JOUR
T1 - Sex Differences in Cardiac Rehabilitation Outcomes
AU - Smith, Joshua R.
AU - Thomas, Randal J.
AU - Bonikowske, Amanda R.
AU - Hammer, Shane M.
AU - Olson, Thomas P.
N1 - Funding Information:
This work was supported by the National Institutes of Health (NR-018832 to T.P. Olson, T32 HL07111 to J.R. Smith and S.M. Hammer, and K12 HD065987 to J.R. Smith). This publication was also made possible through the support of the Mary Kathryn and Michael B. Panitch Career Development Award in Hypertension Research Honoring Gary Schwartz, MD (J.R. Smith).
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/2/18
Y1 - 2022/2/18
N2 - Cardiovascular disease is a leading cause of morbidity and mortality in males and females in the United States and globally. Cardiac rehabilitation (CR) is recommended by the American Heart Association/American College of Cardiology for secondary prevention for patients with cardiovascular disease. CR participation is associated with improved cardiovascular disease risk factor management, quality of life, and exercise capacity as well as reductions in hospital admissions and mortality. Despite these advantageous clinical outcomes, significant sex disparities exist in outpatient phase II CR programming. This article reviews sex differences that are present in the spectrum of care provided by outpatient phase II CR programming (ie, from referral to clinical management). We first review CR participation by detailing the sex disparities in the rates of CR referral, enrollment, and completion. In doing so, we discuss patient, health care provider, and social/environmental level barriers to CR participation with a particular emphasis on those barriers that majorly impact females. We also evaluate sex differences in the core components incorporated into CR programming (eg, patient assessment, exercise training, hypertension management). Next, we review strategies to mitigate these sex differences in CR participation with a focus on automatic CR referral, female-only CR programming, and hybrid CR. Finally, we outline knowledge gaps and areas of future research to minimize and prevent sex differences in CR programming.
AB - Cardiovascular disease is a leading cause of morbidity and mortality in males and females in the United States and globally. Cardiac rehabilitation (CR) is recommended by the American Heart Association/American College of Cardiology for secondary prevention for patients with cardiovascular disease. CR participation is associated with improved cardiovascular disease risk factor management, quality of life, and exercise capacity as well as reductions in hospital admissions and mortality. Despite these advantageous clinical outcomes, significant sex disparities exist in outpatient phase II CR programming. This article reviews sex differences that are present in the spectrum of care provided by outpatient phase II CR programming (ie, from referral to clinical management). We first review CR participation by detailing the sex disparities in the rates of CR referral, enrollment, and completion. In doing so, we discuss patient, health care provider, and social/environmental level barriers to CR participation with a particular emphasis on those barriers that majorly impact females. We also evaluate sex differences in the core components incorporated into CR programming (eg, patient assessment, exercise training, hypertension management). Next, we review strategies to mitigate these sex differences in CR participation with a focus on automatic CR referral, female-only CR programming, and hybrid CR. Finally, we outline knowledge gaps and areas of future research to minimize and prevent sex differences in CR programming.
KW - cardiovascular disease
KW - coronary artery disease
KW - gender identity
KW - heart failure
KW - menopause
KW - morbidity
UR - http://www.scopus.com/inward/record.url?scp=85124777694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124777694&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.121.319894
DO - 10.1161/CIRCRESAHA.121.319894
M3 - Article
C2 - 35175838
AN - SCOPUS:85124777694
SN - 0009-7330
VL - 130
SP - 552
EP - 565
JO - Circulation Research
JF - Circulation Research
IS - 4
ER -